157 related articles for article (PubMed ID: 2951583)
21. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
[TBL] [Abstract][Full Text] [Related]
22. Transient myeloproliferative disease of the newborn: case report with placental, cytogenetic, and flow cytometric findings.
de Tar MW; Dittman W; Gilbert J
Hum Pathol; 2000 Mar; 31(3):396-8. PubMed ID: 10746686
[TBL] [Abstract][Full Text] [Related]
23. Congenital GATA1-mutated myeloproliferative disorder in trisomy 21 complicated by placental fetal thrombotic vasculopathy.
Loh TJ; Lian DW; Iyer P; Lam JC; Kuick CH; Aung AC; Chang KT
Hum Pathol; 2014 Nov; 45(11):2364-7. PubMed ID: 25248574
[TBL] [Abstract][Full Text] [Related]
24. Transient myeloproliferative disorder in a Down's neonate with rearranged T-cell receptor beta gene and evidence of in vivo maturation demonstrated by dual-colour flow cytometric DNA ploidy analysis.
Kwong YL; Cheng G; Tang TS; Robertson EP; Lee CP; Chan LC
Leukemia; 1993 Oct; 7(10):1667-71. PubMed ID: 8412331
[TBL] [Abstract][Full Text] [Related]
25. Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome.
Morgan R; Hecht F; Cleary ML; Sklar J; Link MP
Blood; 1985 Dec; 66(6):1466-8. PubMed ID: 2415189
[TBL] [Abstract][Full Text] [Related]
26. Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate.
Polski JM; Galambos C; Gale GB; Dunphy CH; Evans HL; Batanian JR
J Pediatr Hematol Oncol; 2002 Jan; 24(1):50-4. PubMed ID: 11902741
[TBL] [Abstract][Full Text] [Related]
27. Transient myeloproliferative disorder with 11q23 aberration in two neonates with Down syndrome.
Granzen B; Bernhard B; Reinisch I; Skopnik H; Mertens R
Ann Hematol; 1998; 77(1-2):51-4. PubMed ID: 9760153
[TBL] [Abstract][Full Text] [Related]
28. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
[TBL] [Abstract][Full Text] [Related]
29. Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocytic markers.
Sartori PC; Darbyshire PJ
Pediatr Hematol Oncol; 1991; 8(2):139-45. PubMed ID: 1830754
[TBL] [Abstract][Full Text] [Related]
30. Neonatal myeloproliferative disorders in Down's syndrome and congenital leukemias.
Paolucci G; Rosito P
Haematologica; 1987; 72(6 Suppl):121-5. PubMed ID: 2965083
[No Abstract] [Full Text] [Related]
31. Cryptic deletions and inversions of chromosome 21 in a phenotypically normal infant with transient abnormal myelopoiesis: a molecular cytogenetic study.
Kempski HM; Craze JL; Chessells JM; Reeves BR
Br J Haematol; 1998 Nov; 103(2):473-9. PubMed ID: 9827922
[TBL] [Abstract][Full Text] [Related]
32. Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis.
Miyauchi J; Ito Y; Kawano T; Tsunematsu Y; Shimizu K
Blood; 1992 Sep; 80(6):1521-7. PubMed ID: 1387814
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome.
Kurahashi H; Hara J; Yumura-Yagi K; Murayama N; Inoue M; Ishihara S; Tawa A; Okada S; Kawa-Ha K
Blood; 1991 Mar; 77(6):1161-3. PubMed ID: 1672097
[TBL] [Abstract][Full Text] [Related]
34. Down's syndrome associated with a myeloproliferative disorder.
Okada H; Liu PI; Hoshino T; Yamamoto T; Yamaoka H; Murakami M
Am J Dis Child; 1972 Jul; 124(1):107-10. PubMed ID: 4260742
[No Abstract] [Full Text] [Related]
35. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B
J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165
[TBL] [Abstract][Full Text] [Related]
36. Lineage-specific trisomy 21 in a neonate with resolving transient myeloproliferative syndrome.
Slayton WB; Spangrude GJ; Chen Z; Greene WF; Virshup D
J Pediatr Hematol Oncol; 2002; 24(3):224-6. PubMed ID: 11990311
[TBL] [Abstract][Full Text] [Related]
37. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
Carpenter E; Valverde-Garduno V; Sternberg A; Mitchell C; Roberts I; Vyas P; Vora A
Br J Haematol; 2005 Feb; 128(4):548-51. PubMed ID: 15686466
[TBL] [Abstract][Full Text] [Related]
38. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
[TBL] [Abstract][Full Text] [Related]
39. Transient myeloproliferative disorder associated with trisomy 21, a wide range syndrome: report of two cases with trisomy 21 mosaicism.
Zubizarreta P; Muriel FS; Fernández Barbieri MA
Med Pediatr Oncol; 1995 Jul; 25(1):60-4. PubMed ID: 7753004
[TBL] [Abstract][Full Text] [Related]
40. A chronic myeloproliferative disorder associated with monosomy 7 in the bone marrow cells; normal karyotype in acute transformation.
Linch DC; Walker H; Roberts P; McKinnon J; Goldstone AH; Huehns ER
Br J Haematol; 1982 Jul; 51(3):439-44. PubMed ID: 7104227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
